Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 52 % of short-term debt in 2025; threshold 65 %.
-
Busy address KBO
21 other companies have their registered office at the same address; threshold 10.
Financials
Financial year 2025
Biomedico from Rotselaar, company number BE0793472767, closed financial year 2025 with a result of € 35,408 after tax. For that financial year Biomedico recorded a gross margin of € 426,474 and equity of € 178,528. Compared with financial year 2024, the result moved from € 24,168 to € 35,408. Profitable, and profit is growing. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on February 26, 2026.
€ 178,528
▲ 25% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 35,408
▲ 47% vs 2024
Profit after tax over the fiscal year.
€ 66,375
▲ € 54,372 vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 78,528.
People and assets in 2025
3
Average over the fiscal year, from the social balance sheet.
€ 376,088
▲ 22% vs 2024
€ 125,400 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 3,331
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 420,185
▼ 41% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 65,762
▲ 212% vs 2024
Taxes, VAT and social contributions still to pay.
| 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|
| Gross margin | € 267,840 | € 345,033 | € 426,474 | ▲ 24% |
| Profit after taxes | € 18,952 | € 24,168 | € 35,408 | ▲ 47% |
| Equity | € 118,952 | € 143,120 | € 178,528 | ▲ 25% |
| Total debts | € 148,683 | € 752,276 | € 510,947 | ▼ 32% |
| Cash | € 9,273 | € 12,003 | € 66,375 | ▲ € 54,372 |
| Retained profit | € 18,952 | € 43,120 | € 78,528 | ▲ 82% |
| Balance sheet total | € 267,635 | € 895,396 | € 689,475 | ▼ 23% |
| Employees (FTE) | 2.6 | 3 | 3 |
By gross margin, Biomedico ranks 47th of 115 companies with main activity “Groothandel in farmaceutische en medische artikelen” in Flemish Brabant that publish figures (fiscal year 2025).
Key figures of Biomedico, fiscal years 2023 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
Ask about Biomedico the way you would ask their accountant.
Answers from the filed annual accounts, the Belgian Official Gazette and the CBE register.
Connect ChatGPT or Claude for free- ChatGPT
- Claude
Free account, no payment card. Key figures unlimited, the annual accounts and deeds of 10 companies a month. Need more? Get in touch, we are looking for our first pilot users.
What happened to Biomedico?
What happened at Biomedico in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 35,408 (▲ 47% vs 2024). Source: NBB ↗
- Incorporation, published in the Gazette. Source: Staatsblad ↗
- New establishment in Rotselaar. KBO
In short
From € 18,952 profit in 2023 to € 35,408 profit in 2025.
Paid € 30,633 in corporate taxes since 2023.
Best year ever: 2025, with € 35,408 profit.
On average € 142,200 of value added per employee in 2025.
Management
The stake of BULOPA comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
BiomedicoBehind Biomedico is LOPA MANAGEMENT BV. The shares are held by BULOPA (75%).
Directors
According to the 2025 annual accounts
Director · represented by ROEL BUELENS
Also active at: ROBANO, CASTELEYN HORECAMATERIAAL, INFESTIM, BERTON KOELTECHNIEK, BUMACO KOELTECHNIEK, EVERGREEN, HILUX, WING TOWER +12 more
Shareholders
75%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Stationsstraat 216
3110 Rotselaar
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 21 companies are registered at this address.
All companies at this address →ROBANO same network
€ 188,266 gross margin · 2025
INFESTIM same network
€ 44,152 gross margin · 2025
BERTON KOELTECHNIEK same network
€ 1 million gross margin · 2025
BUMACO KOELTECHNIEK same network
€ 95.4 million revenue · 2025
EVERGREEN same network
€ 964,789 gross margin · 2025
+16 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Similar companies in Flemish Brabant
Same main activity (Groothandel in farmaceutische en medische artikelen), 255 active companies in Flemish Brabant, largest first.
€ 3.6 billion revenue · 2025 · Machelen (Brab.)
Viatris International Supply Point
€ 2.7 billion revenue · 2025 · Hoeilaart
€ 1.2 billion revenue · 2025 · Hoegaarden
€ 799.2 million revenue · 2026 · Leuven
€ 454.7 million revenue · 2025 · Dilbeek
€ 378.6 million revenue · 2025 · Machelen (Brab.)
Website
Technologies
Hosting & Email
Email provider
Outlook.com (free)
Hosting
AS-UNIXSOLUTIONS Unix-Solutions Network, BE
Website info
Features
Security
Shareholders according to the Official Gazette deeds
Who contributed at incorporation and at capital increases, with the deed as source. Later share transfers are not published in the Gazette.
Incorporation
Source: Deed ↗- BULOPA(oprichter) 75%
- LERNOUT, Gorik Edward Mariette(oprichter) 12.5%
- LERNOUT, Tom Wout(oprichter) 12.5%
Details
- Company number
- 0793.472.767
- VAT number
- BE 0793.472.767
- Registered office
- Stationsstraat 216, 3110 Rotselaar
- Names & denominations
- Biomedico
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 10 November 2022
- Peppol
- Active · Active since 1 Dec 2025
- Contact
- biomedico.be
- Activities · NACE
Groothandel in farmaceutische en medische artikelen
Vervaardiging van overige farmaceutische producten
Vervaardiging van machines en apparaten voor klimaatregeling, voor niet-huishoudelijk gebruik
Overige gespecialiseerde bouwactiviteiten, neg
Installatie van verwarming, klimaatregeling, koeling en ventilatie aangedreven door elektriciteit
Overige gespecialiseerde bouwwerkzaamheden